|
|
|
Jefferson researchers use gene therapy for rare, inherited brain disease
A team of scientists, neurosurgeons and physicians at Thomas Jefferson University Hospital are for the first time using a novel form of gene therapy for Canavan disease, a fatal, neurodegenerative childhood disorder. Armed with a new $2.1 million, three-year NIH grant, researchers recently introduced 90 billion copies of a healthy gene into the brains of three children. Their brains lacked the gene, which makes an enzyme that breaks down an acid substance in the brain. National Institute of Neurological Disease and Stroke Contact:
Steve Benowitz
steven.benowitz@mail.tju.edu
215-955-5291
Thomas Jefferson University
Message posted by: Wouter Kalle
|
|
Variants Associated with Pediatric Allergic Disorder
Mutations in PHF6 Found in T-Cell Leukemia
Genetic Risk Variant for Urinary Bladder Cancer
Antibody Has Therapeutic Effect on Mice with ALS
Regulating P53 Activity in Cancer Cells
Anti-RNA Therapy Counters Breast Cancer Spread
Mitochondrial DNA Diversity
The Power of RNA Sequencing
‘Pro-Ageing' Therapy for Cancer?
Niche Genetics Influence Leukaemia
Molecular Biology: Clinical Promise for RNA Interference
Chemoprevention Cocktail for Colon Cancer
more news ...
|